A sea change in diagonosing and managing HPV and cervical disease- Part 1

Contemporary Ob/Gyn

Volumn 47, Issue 5, 2002, Pages 42-56

  Richart, Ralph M ^a   Wilkinson, Edward J ^a  

^a Bureaus of Cylyc and Digene ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950000380     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. American College of Obstetricians and Gynecologists. Cervical cytology: evaluation and management of abnormalities. ACOG Technical Bulletin, 1993.
2. Kurman RJ, Henson DE, Herbst AL, et al. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute workshop. JAMA. 1994;271:1866-1869.
3. Cox JT, Wilkinson EJ, Lonky N, et al. ASCCP Practice Guidelines. Management guidelines for the follow-up of atypical squamous cells of undetermined significance (ASCUS). J Lower Genital Tract Dis. 2000;4:99-105.
4. Cox JT, Massad TS, Lonky N, et al. ASCCP Practice Guidelines. Management guidelines for the follow-up of cytology read as low grade squamous intraepithelial lesion. J Lower Genital Tract Dis. 2000;4:83-92.
5. Cox JT. ASCCP Practice Guideline: Management of glandular abnormalities in the cervical smear. J Lower Genital Tract Dis. 1997;1:41-45.
6. Sherman ME, Tabbara SO, Scott DR, et al. "ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol. 1999;12:335-342.
7. Crum CP, Genest DR, Krane JF, et al. Subclassifying atypical squamous cells in Thin-Prep cervical cytology correlates with detection of high-risk human papillomavirus DNA. Am J Clin Pathol. 1999;112:384-390.
8. Solomon D, Schiffman M, Tarrone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Instit. 2001;93:293-299.
9. Manos MM, Kinney WK, Hurley LB. et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
10. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Instit. 1995;87:779-780.